CD79A and shigellosis: Conclusions derived from these studies indicate that parenterally immunized subjects protected after challenge show a robust LPS-specific systemic/memory immune responses including higher IgG+ BM cell responses as compared to orally challenged subjects developing shigellosis who showed a stronger correlation with LPS-specific mucosal responses as well as higher IgA+ BM cell responses [18].